4//SEC Filing
Tahir Misbah 4
Accession 0001415889-25-023463
CIK 0001842295other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 6:30 PM ET
Size
5.6 KB
Accession
0001415889-25-023463
Insider Transaction Report
Form 4
Tahir Misbah
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-09-02+325,000→ 325,000 totalExercise: $15.32Exp: 2035-09-01→ Common Stock (325,000 underlying)
Footnotes (1)
- [F1]The option shall vest as to 1/4th of the total award on September 2, 2026, and thereafter shall vest as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
Documents
Issuer
Maze Therapeutics, Inc.
CIK 0001842295
Entity typeother
Related Parties
1- filerCIK 0001787359
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 6:30 PM ET
- Size
- 5.6 KB